1. Up Front

   Up front 01 July 2016 Pages: 1577 - 1578

2. Islet biology, the CDKN2A/B locus and type 2 diabetes risk

   • Yahui Kong
   • Rohit B. Sharma
   • Laura C. Alonso

   Review 07 May 2016 Pages: 1579 - 1593

   

3. Diabetic macular oedema: pathophysiology, management challenges and treatment resistance

   • Bobak Bahrami
   • Meidong Zhu
   • Andrew Chang

   Review 14 May 2016 Pages: 1594 - 1608

   

4. Cerebral cortex: a target and source of insulin?

   • Éva A. Csajbók
   • Gábor Tamás

   Review 20 May 2016 Pages: 1609 - 1615

   

5. Angiopoietins and diabetic nephropathy

   • Luigi Gnudi

   Mini-Review Open access 20 May 2016 Pages: 1616 - 1620

   

6. Novel anti-inflammatory drugs for the treatment of diabetic kidney disease

   • Hiddo J. L. Heerspink
   • Dick De Zeeuw

   Commentary Open access 23 June 2016 Pages: 1621 - 1623

7. JAK inhibition in the treatment of diabetic kidney disease

   • Frank C. Brosius
   • Katherine R. Tuttle
   • Matthias Kretzler

   Mini-review 22 June 2016 Pages: 1624 - 1627

8. Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot

   • Hood Thabit
   • Lalantha Leelarathna

   Commentary Open access 10 June 2016 Pages: 1628 - 1631

9. Can somatostatin antagonism prevent hypoglycaemia during exercise in type 1 diabetes?

   • Nadine Taleb
   • Rémi Rabasa-Lhoret

   Commentary 06 May 2016 Pages: 1632 - 1635

   

10. Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study

    • Sybil A. McAuley
    • Jodie C. Horsburgh
    • David N. O’Neal

    Article 11 May 2016 Pages: 1636 - 1644

    

11. Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

    • Ralph A. DeFronzo
    • John B. Buse
    • Mark Fineman

    Article Open access 23 May 2016 Pages: 1645 - 1654

    

12. Interaction between rs10830963 polymorphism in MTNR1B and lifestyle intervention on occurrence of gestational diabetes

    • Nora E. Grotenfelt
    • Niko S. Wasenius
    • Johan G. Eriksson

    Short Communication 21 May 2016 Pages: 1655 - 1658

    

13. Twenty year fitness trends in young adults and incidence of prediabetes and diabetes: the CARDIA study

    • Lisa S. Chow
    • Andrew O. Odegaard
    • Pamela J. Schreiner

    Article 16 May 2016 Pages: 1659 - 1665

14. Family history of myocardial infarction, stroke and diabetes and cardiometabolic markers in children

    • Nina E. Berentzen
    • Alet H. Wijga
    • Henriëtte A. Smit

    Article 30 May 2016 Pages: 1666 - 1674

15. Parenthood and the risk of diabetes in men and women: a 7 year prospective study of 0.5 million individuals

    • Sanne A. E. Peters
    • Ling Yang
    • on behalf of the China Kadoorie Biobank Collaboration Group

    Article Open access 18 May 2016 Pages: 1675 - 1682

    

16. Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men

    • Rachel Dankner
    • Paolo Boffetta
    • Laurence S. Freedman

    Article Open access 17 May 2016 Pages: 1683 - 1691

    

17. Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013

    • Anna Norhammar
    • Johan Bodegård
    • David Nathanson

    Article 18 May 2016 Pages: 1692 - 1701

    

18. Excess maternal transmission of variants in the THADA gene to offspring with type 2 diabetes

    • Rashmi B. Prasad
    • Anna Lessmark
    • Leif Groop

    Article 07 May 2016 Pages: 1702 - 1713

    

19. DNA hypermethylation of CD3⁺ T cells from cord blood of infants exposed to intrauterine growth restriction

    • Lyda Williams
    • Yoshinori Seki
    • Maureen J. Charron

    Article 17 May 2016 Pages: 1714 - 1723

    

20. Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes

    • Erwan Leclair
    • Richard T. Liggins
    • Michael C. Riddell

    Article 13 April 2016 Pages: 1724 - 1731

    

21. A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes

    • Hung-Tsung Wu
    • Horng-Yih Ou
    • Chih-Jen Chang

    Article 25 May 2016 Pages: 1732 - 1742

    

22. Lysosomal acid lipase regulates VLDL synthesis and insulin sensitivity in mice

    • Branislav Radović
    • Nemanja Vujić
    • Dagmar Kratky

    Article Open access 06 May 2016 Pages: 1743 - 1752

    

23. Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity

    • Ahmad Al-Mrabeh
    • Kieren G. Hollingsworth
    • Roy Taylor

    Article Open access 14 May 2016 Pages: 1753 - 1759

    

24. Serum amyloid A links endotoxaemia to weight gain and insulin resistance in mice

    • Edson M. de Oliveira
    • Thais P. Ascar
    • Ana Campa

    Article 28 April 2016 Pages: 1760 - 1768

    

25. Loss of BMP receptor type 1A in murine adipose tissue attenuates age-related onset of insulin resistance

    • Tim J. Schulz
    • Antonia Graja
    • Yu-Hua Tseng

    Article Open access 21 May 2016 Pages: 1769 - 1777

    

26. The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis

    • Bryna S. M. Chow
    • Christine Koulis
    • Terri J. Allen

    Article 11 May 2016 Pages: 1778 - 1790

    

27. Erratum to: A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)

    • Katrien Benhalima
    • Chantal Mathieu
    • Fidelma Dunne

    Erratum 18 May 2016 Pages: 1791 - 1791